115 related articles for article (PubMed ID: 37926648)
1. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer.
Liu KH; Yang W; Tian HP
Clin Radiol; 2024 Feb; 79(2):e264-e272. PubMed ID: 37926648
[TBL] [Abstract][Full Text] [Related]
2. Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient´s immunotherapy selection.
Liu K; Yang W; Tian H; Li Y; He J
Eur Radiol; 2024 Apr; ():. PubMed ID: 38637428
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
[TBL] [Abstract][Full Text] [Related]
4. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Combined Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Diffusion Tensor Imaging in Predicting Parametrial Infiltration in Cervical Cancer.
Lin TT; Li XX; Lv WF; Dong JN; Wei C; Wang TT; Wang CB; Zhang P
Contrast Media Mol Imaging; 2021; 2021():6651070. PubMed ID: 34054375
[TBL] [Abstract][Full Text] [Related]
6. Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio.
Li X; Wang P; Li D; Zhu H; Meng L; Song Y; Xie L; Zhu J; Yu T
Eur Radiol; 2018 May; 28(5):1875-1883. PubMed ID: 29222676
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.
Kucukgoz Gulec U; Kilic Bagir E; Paydas S; Guzel AB; Gumurdulu D; Vardar MA
Arch Gynecol Obstet; 2019 Aug; 300(2):377-382. PubMed ID: 31076855
[TBL] [Abstract][Full Text] [Related]
8. Predicting treatment response to concurrent chemoradiotherapy in squamous cell carcinoma of the cervix using amide proton transfer imaging and intravoxel incoherent motion imaging.
Deng X; Liu M; Zhou Q; Zhao X; Li M; Zhang J; Shen H; Lan X; Zhang X; Zhang J
Diagn Interv Imaging; 2022 Dec; 103(12):618-624. PubMed ID: 36151042
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
[TBL] [Abstract][Full Text] [Related]
10. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
11. Quantitative study of preoperative staging of gastric cancer using intravoxel incoherent motion diffusion-weighted imaging as a potential clinical index.
Zeng Q; Hong Y; Cheng J; Cai W; Zhuo H; Hou J; Wang L; Lu Y; Cai J
Eur J Radiol; 2021 Aug; 141():109627. PubMed ID: 34126429
[TBL] [Abstract][Full Text] [Related]
12. Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.
Bortolotto C; Stella GM; Messana G; Lo Tito A; Podrecca C; Nicora G; Bellazzi R; Gerbasi A; Agustoni F; Grimm R; Zacà D; Filippi AR; Bottinelli OM; Preda L
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428726
[TBL] [Abstract][Full Text] [Related]
13. Relationship between
Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma.
Kucukgoz Gulec U; Kilic Bagir E; Paydas S; Guzel AB; Gumurdulu D; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():51-55. PubMed ID: 31739121
[TBL] [Abstract][Full Text] [Related]
15. A histogram analysis of diffusion and perfusion features of cervical cancer based on intravoxel incoherent motion magnetic resonance imaging.
Thapa D; Wang P; Wu G; Wang X; Sun Q
Magn Reson Imaging; 2019 Jan; 55():103-111. PubMed ID: 29953932
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion diffusion weighted MRI of cervical cancer - Correlated with tumor differentiation and perfusion.
Zhou Y; Liu J; Liu C; Jia J; Li N; Xie L; Zhou Z; Zhang Z; Zheng D; He W; Shen Y; Lu W; Zhu H
Magn Reson Imaging; 2016 Oct; 34(8):1050-6. PubMed ID: 27133158
[TBL] [Abstract][Full Text] [Related]
17. Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
Chen L; Lucas E; Zhang X; Liu Q; Zhuang Y; Lin W; Chen H; Zhou F
Histopathology; 2022 Jan; 80(2):338-347. PubMed ID: 34455625
[TBL] [Abstract][Full Text] [Related]
18. Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer.
Kim M; Kim H; Suh DH; Kim K; Kim H; Kim YB; No JH
Anticancer Res; 2017 Sep; 37(9):5087-5094. PubMed ID: 28870938
[TBL] [Abstract][Full Text] [Related]
19. Uncovering PD-L1 and CD8
Chen J; Gu P; Wu H
Biomed Res Int; 2020; 2020():8164365. PubMed ID: 32884946
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
Gao Y; Li S; Xu D; Chen S; Cai Y; Jiang W; Zhang X; Sun J; Wang K; Chang B; Wang F; Hong M
Chin J Cancer; 2017 Jul; 36(1):61. PubMed ID: 28754154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
